Drug class
Class Ia antiarrhythmic; cardiac fast sodium-channel blocker
Mechanism of action
Blocks fast voltage-gated sodium channels in cardiac myocytes, slowing phase-0 depolarisation and conduction velocity. Class Ia activity also prolongs action-potential duration and effective refractory period through effects on repolarising potassium currents.
General use cases
- Historically used for treatment of selected supraventricular and ventricular arrhythmias in countries where prajmalium remains authorised; availability and clinical role are jurisdiction-specific.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
